Analysis
Radical Numerics raised $50 million in a round led by Emergence Capital to develop AI models that simulate biological systems. The company is applying foundation-model methods to the problem of modeling cells, proteins, and living processes -- the biological analogue of the 'world models' that simulate physical environments for robotics.
The round sits within a broader 2026 surge of capital into AI-for-science, where investors are funding teams that aim to compress the slow, expensive cycle of biological experimentation with predictive simulation. If the models work, they could accelerate drug discovery and life-sciences research; if they don't, they join a long history of computational-biology bets that over-promised.
For builders, the honest framing matters: simulation models are powerful accelerants for scientists, not replacements, and the credible pitch is augmenting wet-lab work with faster in-silico iteration rather than claiming autonomous discovery.
